These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 16949048

  • 1. Identification of BRCA1 and BRCA2 mutations from Korean breast cancer patients using denaturing HPLC.
    Kim BY, Lee DG, Lee KR, Han SH, Surendran S, Han CW, Chung N.
    Biochem Biophys Res Commun; 2006 Oct 20; 349(2):604-10. PubMed ID: 16949048
    [Abstract] [Full Text] [Related]

  • 2. Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer.
    Han SH, Lee KR, Lee DG, Kim BY, Lee KE, Chung WS.
    Clin Genet; 2006 Dec 20; 70(6):496-501. PubMed ID: 17100994
    [Abstract] [Full Text] [Related]

  • 3. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.
    Choi DH, Lee MH, Bale AE, Carter D, Haffty BG.
    J Clin Oncol; 2004 May 01; 22(9):1638-45. PubMed ID: 15117986
    [Abstract] [Full Text] [Related]

  • 4. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
    Seo JH, Cho DY, Ahn SH, Yoon KS, Kang CS, Cho HM, Lee HS, Choe JJ, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS, Son GS, Lee JB, Koo BH.
    Hum Mutat; 2004 Oct 01; 24(4):350. PubMed ID: 15365993
    [Abstract] [Full Text] [Related]

  • 5. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
    Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, Shao ZM.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 16; 85(43):3030-4. PubMed ID: 16324400
    [Abstract] [Full Text] [Related]

  • 6. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
    Ratajska M, Brozek I, Senkus-Konefka E, Jassem J, Stepnowska M, Palomba G, Pisano M, Casula M, Palmieri G, Borg A, Limon J.
    Oncol Rep; 2008 Jan 16; 19(1):263-8. PubMed ID: 18097605
    [Abstract] [Full Text] [Related]

  • 7. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
    van der Hout AH, van den Ouweland AM, van der Luijt RB, Gille HJ, Bodmer D, Brüggenwirth H, Mulder IM, van der Vlies P, Elfferich P, Huisman MT, ten Berge AM, Kromosoeto J, Jansen RP, van Zon PH, Vriesman T, Arts N, Lange MB, Oosterwijk JC, Meijers-Heijboer H, Ausems MG, Hoogerbrugge N, Verhoef S, Halley DJ, Vos YJ, Hogervorst F, Ligtenberg M, Hofstra RM.
    Hum Mutat; 2006 Jul 16; 27(7):654-66. PubMed ID: 16683254
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
    Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA.
    J Natl Cancer Inst; 2006 Dec 06; 98(23):1694-706. PubMed ID: 17148771
    [Abstract] [Full Text] [Related]

  • 10. Pitfalls and caveats in BRCA sequencing.
    Bellosillo B, Tusquets I.
    Ultrastruct Pathol; 2006 Dec 06; 30(3):229-35. PubMed ID: 16825125
    [Abstract] [Full Text] [Related]

  • 11. High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
    Torres D, Rashid MU, Gil F, Umana A, Ramelli G, Robledo JF, Tawil M, Torregrosa L, Briceno I, Hamann U.
    Breast Cancer Res Treat; 2007 Jun 06; 103(2):225-32. PubMed ID: 17080309
    [Abstract] [Full Text] [Related]

  • 12. BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations.
    Ahn SH, Son BH, Yoon KS, Noh DY, Han W, Kim SW, Lee ES, Park HL, Hong YJ, Choi JJ, Moon SY, Kim MJ, Kim KH, Kwak BS, Cho DY.
    Cancer Lett; 2007 Jan 08; 245(1-2):90-5. PubMed ID: 16455195
    [Abstract] [Full Text] [Related]

  • 13. Molecular and in silico analysis of BRCA1 and BRCA2 variants.
    Tommasi S, Pilato B, Pinto R, Monaco A, Bruno M, Campana M, Digennaro M, Schittulli F, Lacalamita R, Paradiso A.
    Mutat Res; 2008 Sep 26; 644(1-2):64-70. PubMed ID: 18694767
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
    Hansen Tv, Jønson L, Albrechtsen A, Andersen MK, Ejlertsen B, Nielsen FC.
    Breast Cancer Res Treat; 2009 May 26; 115(2):315-23. PubMed ID: 18546071
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland.
    Brozek I, Ochman K, Debniak J, Morzuch L, Ratajska M, Stepnowska M, Stukan M, Emerich J, Limon J.
    Gynecol Oncol; 2008 Feb 26; 108(2):433-7. PubMed ID: 17997147
    [Abstract] [Full Text] [Related]

  • 18. Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.
    Hartikainen JM, Kataja V, Pirskanen M, Arffman A, Ristonmaa U, Vahteristo P, Ryynänen M, Heinonen S, Kosma VM, Mannermaa A.
    Clin Genet; 2007 Oct 26; 72(4):311-20. PubMed ID: 17850627
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil.
    Gomes MC, Costa MM, Borojevic R, Monteiro AN, Vieira R, Koifman S, Koifman RJ, Li S, Royer R, Zhang S, Narod SA.
    Breast Cancer Res Treat; 2007 Jul 26; 103(3):349-53. PubMed ID: 17063270
    [Abstract] [Full Text] [Related]

  • 20. Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark.
    Thomassen M, Gerdes AM, Cruger D, Jensen PK, Kruse TA.
    Cancer Genet Cytogenet; 2006 Jul 15; 168(2):168-71. PubMed ID: 16843109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.